* Axonics Inc AXNX.OQ AXNX.O is expected to show a rise
in
quarterly revenue when it reports results on July 27.
* The Irvine California-based company is expected to report
a
25.4% increase in revenue to $86.507 million from $68.98 million
a year ago, according to the mean estimate from 13 analysts,
based on Refinitiv data.
* Refinitiv's mean analyst estimate for Axonics Inc is for
a loss
of 11 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 13 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Axonics Inc
is
$75, above its last closing price of $54.16.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Mar. 31 2023 -0.28 -0.29 -0.19 Beat 34.4
Dec. 31 2023 -0.27 -0.24 0.01 Beat 104.1
Sep. 30 2022 -0.48 -0.48 -0.34 Beat 28.5
Jun. 30 2022 -0.54 -0.54 -0.47 Beat 13.4
Mar. -0.65 -0.63 -0.50 Beat 21
31 2022
Dec. 31 2021 -0.37 -0.37 -0.34 Beat 8.1
Sep. 30 2021 -0.43 -0.43 -0.38 Beat 11.9
Jun. 30 2021 -0.48 -0.49 -0.59 Missed -20.2
This summary was machine generated July 25 at 22:29 GMT. All
figures in US dollars unless otherwise stated